UK becomes first country to approve Crispr gene-editing therapy
Published
The UK has become the first country to approve a therapy based on Crispr gene editing, with the regulator authorizing a treatment for sickle cell disease and beta thalassemia. The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by…
#healthcare #crisprtherapeutics #jenniferdoudna #anobelprize #budget #jeremyhunt #julianbeach #mhra #financialtimesltd